Earnings Feed
Start Free
BeOne Medicines Ltd.·4

Jul 17, 5:31 PM ET

OYLER JOHN 4

4 · BeOne Medicines Ltd. · Filed Jul 17, 2026

Research Summary

AI-generated summary of this filing

Updated

BeOne (ONC) CEO John Oyler Exercises Options, Sells Shares

What Happened
John Oyler, CEO of BeOne Medicines (ONC), exercised stock derivatives and immediately sold the resulting shares in open-market transactions on July 15–16, 2026. He exercised 283,154 shares across several option/derivative lots (examples: 35,605 @ $100.04; 76,677 @ $169.58; 96,501 @ $160.40; 70,096 @ $119.96), paying roughly $41.14 million in exercise costs. He sold 283,154 shares in multiple transactions at prices roughly in the $310–$323 range, generating approximately $89.35 million in gross proceeds. The exercised-and-sold share counts match, indicating the exercised shares were sold immediately (a cashless-style outcome).

Key Details

  • Transaction dates: July 15–16, 2026. Form filed July 17, 2026 (timely).
  • Exercise (acquired): 283,154 shares; total cash paid ≈ $41.14M (various exercise prices listed in form).
  • Open-market sales (disposed): 283,154 shares; total proceeds ≈ $89.35M; reported sale prices (weighted averages) ranged roughly $309.31 to $323.63 across multiple transactions.
  • Additional derivative entries: the filing also shows several "exercise/conversion" line items recorded as disposed at $0 (totaling 3,681,002 shares reported as disposed at $0) — these are recorded as derivative conversions in the filing.
  • Notable footnotes: sales were effected under a Rule 10b5-1 trading plan adopted March 10, 2026 (F7); each American Depositary Share (ADS) represents 13 ordinary shares (F6); several footnotes note weighted-average prices across multiple trades and trust/IRA holdings where the reporting person disclaims beneficial ownership (F1–F5, F10–F23).
  • Post-transaction holdings: the filing extract provided here does not state Oyler’s total holdings after these transactions.

Context

  • For retail investors: purchases (insider buys) are often taken as a stronger forward-looking signal than routine sales. This filing shows an exercise followed by immediate sales (common when insiders exercise options and sell shares to cover exercise/tax costs).
  • Derivative explanation: the filing records multiple option/derivative exercises (code M). When exercised shares are sold the same day, it functions like a cashless exercise—insider converts options into shares and sells them rather than holding new shares.
  • If you want full trade-by-trade pricing or to confirm post-transaction holdings, consult the full Form 4 on the SEC EDGAR site (accession 0001042047-26-000014) and the filing footnotes for the precise breakdown of weighted-average prices.

Insider Transaction Report

Form 4
Period: 2026-07-15
BeOne Medicines Ltd.ONC
OYLER JOHN
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    American Depositary Shares

    [F6]
    2026-07-15$100.04/sh+35,605$3,561,924→ 35,605 total
  • Exercise/Conversion

    American Depositary Shares

    [F6]
    2026-07-15$169.58/sh+76,677$13,002,886→ 112,282 total
  • Exercise/Conversion

    American Depositary Shares

    [F6]
    2026-07-15$160.40/sh+4,275$685,710→ 116,557 total
  • Sale

    American Depositary Shares

    [F6][F7][F8]
    2026-07-15$310.02/sh−6,067$1,880,892→ 110,490 total
  • Sale

    American Depositary Shares

    [F6][F7][F9]
    2026-07-15$310.92/sh−41,336$12,852,305→ 69,154 total
  • Sale

    American Depositary Shares

    [F6][F7][F10]
    2026-07-15$311.71/sh−12,857$4,007,685→ 56,297 total
  • Sale

    American Depositary Shares

    [F6][F7][F11]
    2026-07-15$312.86/sh−48,657$15,222,746→ 7,640 total
  • Sale

    American Depositary Shares

    [F6][F7][F12]
    2026-07-15$313.58/sh−7,640$2,395,746→ 0 total
  • Exercise/Conversion

    American Depositary Shares

    [F6]
    2026-07-16$160.40/sh+96,501$15,478,760→ 96,501 total
  • Exercise/Conversion

    American Depositary Shares

    [F6]
    2026-07-16$119.96/sh+70,096$8,408,716→ 166,597 total
  • Sale

    American Depositary Shares

    [F6][F7]
    2026-07-16$311.98/sh−233$72,691→ 166,364 total
  • Sale

    American Depositary Shares

    [F6][F7][F13]
    2026-07-16$314.08/sh−4,881$1,533,011→ 161,483 total
  • Sale

    American Depositary Shares

    [F6][F7][F14]
    2026-07-16$314.73/sh−9,516$2,994,988→ 151,967 total
  • Sale

    American Depositary Shares

    [F6][F7][F15]
    2026-07-16$316.00/sh−19,752$6,241,632→ 132,215 total
  • Sale

    American Depositary Shares

    [F6][F7][F16]
    2026-07-16$316.82/sh−32,224$10,209,121→ 99,991 total
  • Sale

    American Depositary Shares

    [F6][F7][F17]
    2026-07-16$317.79/sh−42,798$13,600,721→ 57,193 total
  • Sale

    American Depositary Shares

    [F6][F7][F18]
    2026-07-16$318.55/sh−6,402$2,039,353→ 50,791 total
  • Sale

    American Depositary Shares

    [F6][F7][F19]
    2026-07-16$319.99/sh−15,097$4,830,934→ 35,694 total
  • Sale

    American Depositary Shares

    [F6][F7][F20]
    2026-07-16$321.00/sh−20,505$6,582,064→ 15,189 total
  • Sale

    American Depositary Shares

    [F6][F7][F21]
    2026-07-16$321.61/sh−13,109$4,216,021→ 2,080 total
  • Sale

    American Depositary Shares

    [F6][F7][F22]
    2026-07-16$322.71/sh−1,560$503,424→ 520 total
  • Sale

    American Depositary Shares

    [F6][F7][F23]
    2026-07-16$323.59/sh−520$168,265→ 0 total
  • Exercise/Conversion

    Share Option (Right to Buy)

    [F24][F25]
    2026-07-15−462,865→ 1 total
    Exercise: $7.70Exp: 2027-09-26→ Ordinary Shares (462,865 underlying)
  • Exercise/Conversion

    Share Option (Right to Buy)

    [F24][F26]
    2026-07-15−996,801→ 9 total
    Exercise: $13.05Exp: 2028-04-29→ Ordinary Shares (996,801 underlying)
  • Exercise/Conversion

    Share Option (Right to Buy)

    [F24][F27]
    2026-07-15−55,575→ 1,254,513 total
    Exercise: $12.34Exp: 2028-06-25→ Ordinary Shares (55,575 underlying)
  • Exercise/Conversion

    Share Option (Right to Buy)

    [F24][F27]
    2026-07-16−1,254,513→ 0 total
    Exercise: $12.34Exp: 2028-06-25→ Ordinary Shares (1,254,513 underlying)
  • Exercise/Conversion

    Share Option (Right to Buy)

    [F24][F28]
    2026-07-16−911,248→ 1,282,034 total
    Exercise: $9.23Exp: 2029-06-04→ Ordinary Shares (911,248 underlying)
Holdings

  • Ordinary Shares

    5,445,917

  • Ordinary Shares

    [F1]
    (indirect: See Footnote)
    481,533

  • Ordinary Shares

    [F2]
    (indirect: See Footnote)
    7,699,158

  • Ordinary Shares

    [F3]
    (indirect: See Footnote)
    28,204,115

  • Ordinary Shares

    [F4]
    (indirect: See Footnote)
    9,545,000

  • Ordinary Shares

    [F5]
    (indirect: See Footnote)
    102,188
Footnotes (28)
  • [F1]These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.35 to $312.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.35 to $313.345, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.36 to $313.90, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.27 to $314.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.27 to $315.24, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F15]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.28 to $316.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F16]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.28 to $317.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F17]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.28 to $318.265, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F18]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.30 to $319.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F19]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.36 to $320.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F2]These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
  • [F20]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.38 to $321.35, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F21]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.39 to $322.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F22]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.455 to $323.405, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F23]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.495 to $323.625, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F24]The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
  • [F25]These securities vest over a four-year period as follows: 25% on June 30, 2018, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events.
  • [F26]These securities vest over a four-year period as follows: 25% on April 30, 2019, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events.
  • [F27]These securities vest over a four-year period as follows: 25% on June 26, 2019, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events.
  • [F28]These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events.
  • [F3]These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interests are owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
  • [F4]These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
  • [F5]These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.
  • [F6]Each American Depositary Share represents 13 Ordinary Shares.
  • [F7]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.31 to $310.30, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.35 to $311.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Signature
/s/ Frank Collazo, as Attorney-in-Fact|2026-07-17

Documents

1 file
  • 4
    wk-form4_1784323860.xmlPrimary

    FORM 4